Suchergebnisse - "Caravita, Tommaso"

PubPharm (9)

1

Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form

enthalten in: Cancer | 2012

von Rago, A. | Grammatico, S. | Za, T. | +23

2

A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma

enthalten in: Cancer | 2008

von Musto, P. | Petrucci, M. | Bringhen, S. | +10

ErratumIn: Cancer. 2008 Nov 15;113(10):2835

3

A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma

enthalten in: Cancer | 2008

von Musto, P. | Petrucci, M. | Bringhen, S. | +9

4

Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy

enthalten in: Cancer | 2007

von Palumbo, A. | Bringhen, S. | Falco, P. | +7

5

Characterization of Ph-negative abnormal clones emerging during imatinib therapy

enthalten in: Cancer | 2007

von Abruzzese, E. | Gozzetti, A. | Galimberti, S. | +7

6

Characterization of Ph-negative abnormal clones emerging during imatinib therapy

enthalten in: Cancer | 2007

von Abruzzese, E. | Gozzetti, A. | Galimberti, S. | +7

7

Time to first disease progression, but not β2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy

enthalten in: Cancer | 2007

von Palumbo, A. | Bringhen, S. | Falco, P. | +7

8

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma

enthalten in: Cancer | 2005

von Palumbo, A. | Bertola, A. | Musto, P. | +7

9

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma

enthalten in: Cancer | 2005

von Palumbo, A. | Bertola, A. | Musto, P. | +6

1
[1]